Advertisement
Screener

Foghorn Therapeutics Inc. (FHTX) Total Long-Term Debt

2.8 / 5 stars · 68/120 Roast Me

Foghorn Therapeutics Inc. Total Long-Term Debt

Foghorn Therapeutics Inc. (FHTX) had Total Long-Term Debt of $19.91 million as of 2021-09-30, per its 10-Q filed 2021-11-09.

Discontinued › Balance Sheet › Liabilities › Debt

us-gaap:LongTermDebt · last filed 2021-11-09

  • 2021-09-30: Long-term Debt $19.91M.
  • 2021-06-30: Long-term Debt $19.83M.
  • 2021-03-31: Long-term Debt $19.74M.
  • 2020-12-31: Long-term Debt $19.65M.
Period endLong-term Debt
2021-09-30$19.91M
10-Q · filed 2021-11-09
2021-06-30$19.83M
10-Q · filed 2021-08-10
2021-03-31$19.74M
10-Q · filed 2021-05-11
2020-12-31$19.65M
10-Q · filed 2021-11-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Eledon Pharmaceuticals, Inc. (ELDN)United States$0.219B-3.23
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B
Nkarta, Inc. (NKTX)United States$0.205B-1.73
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
ORAMED PHARMACEUTICALS INC. (ORMP)$0.199B1.13
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Zentalis Pharmaceuticals, Inc. (ZNTL)United States$0.196B-2.48
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37